Nicotine reduces the secretion of Alzheimer's β-amyloid precursor protein containing β-amyloid peptide in the rat without altering synaptic proteins

Annals of the New York Academy of Sciences

Volumn 965, Issue , 2002, Pages 364-372

  Lahiri, D K ^a   Utsuki, T ^b   Chen, D ^a   Farlow, M R ^a   Shoaib, M ^b   Ingram, D K ^b   Greig, N H ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Cholinergic system; Nicotine; Synaptic proteins; amyloid peptide; amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CEREBROSPINAL FLUID; CHOLINERGIC NERVE CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

ANIMALIA;

EID: 0036295594     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04178.x     Document Type: Conference Paper

References (32)

1. The cholinergic system
2. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
3. Nicotinic treatment of Alzheimer's disease
4. Cognitive effects of nicotine
5. Smoking and Alzheimer's disease: A review of the epidemiological evidence
6. Muscarinic and nicotinic binding sites in Alzheimer's disease cerebral cortex
7. 3H]-nicotine binding sites in human brain
8. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
9. The effect of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer's type
10. Characterization of the locomotor stimulant action of nicotine in tolerant rats
11. 3]-chlorisondamine
12. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
13. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors
14. Alzheimer's disease: Genotypes, phenotype, and treatment
15. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats
16. Tacrine alters the secretion of beta-amyloid precursor protein in cell lines
17. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells
18. Pharmacological modulation of Alzheimer's β-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions
19. Membrane trafficking in the presynaptic nerve terminal
20. An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence
21. Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats
22. Rodent model of nicotine abstinence syndrome
23. Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine
24. Cholinergic activity and amyloid precursor protein metabolism
25. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor
26. Both α and β subunits contribute to the agonist sensitivity of neuronal nicotinic receptors
27. Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation
28. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors
29. Nicotine inhibits amyloid formation by the beta-peptide
30. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity
31. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity
32. Nicotine and amyloid formation